1. Home
  2. ZM vs NTRA Comparison

ZM vs NTRA Comparison

Compare ZM & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zoom Video Communications Inc.

ZM

Zoom Video Communications Inc.

HOLD

Current Price

$87.53

Market Cap

25.0B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZM
NTRA
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0B
27.0B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
ZM
NTRA
Price
$87.53
$244.06
Analyst Decision
Buy
Strong Buy
Analyst Count
23
16
Target Price
$92.19
$227.69
AVG Volume (30 Days)
3.4M
1.7M
Earning Date
11-24-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
71.29
N/A
EPS
5.13
N/A
Revenue
$4,805,915,000.00
$2,116,676,000.00
Revenue This Year
$6.70
$32.77
Revenue Next Year
$3.35
$16.51
P/E Ratio
$17.09
N/A
Revenue Growth
3.85
38.17
52 Week Low
$64.41
$125.38
52 Week High
$91.04
$245.59

Technical Indicators

Market Signals
Indicator
ZM
NTRA
Relative Strength Index (RSI) 62.23 80.03
Support Level $83.99 $233.67
Resistance Level $86.98 $240.18
Average True Range (ATR) 2.70 7.39
MACD 0.55 0.68
Stochastic Oscillator 75.00 97.49

Price Performance

Historical Comparison
ZM
NTRA

About ZM Zoom Video Communications Inc.

Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: